Reportstack has announced a new market report on MediPoint: Peripheral Vascular Stents for the Lower Extremity - Global Analysis and Market Forecasts.
Endovascular therapies such as stenting have been widely adopted to
treat peripheral artery disease in the lower extremity. Peripheral
vascular stents including bare metal, drug-eluting, covered and
bioabsorbable stents are associated with improved clinical outcomes
compared to balloon angioplasty alone. The global peripheral vascular
stent (PVS) market is steadily growing in the 10 countries covered in
the report, including the US, France, Germany, Italy, Spain, UK, Japan,
Brazil, China and India.
It is evident that currently the peripheral vascular stent market for the lower extremity is saturated with bare metal stents, followed by covered stents. However, as clinical data and appropriate reimbursement and costs are established, adoption of innovative stent technologies such as drug-eluting stents and bioabsorbable stents will increase in the future.
By the end of the forecast period, the competitive landscape will experience significant change due to the launch of bioabsorbable stents in the market, the expansion of approved indications to include infrapopliteal artery lesions and the entry of new companies such as 480 Biomedical. Regions Covered: US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and India.
Market Model Features
An interactive excel forecast model based on primary research interviews and surveys with KOLs, physicians, industry participants and distributors is included in this report*. The forecast model is robust, fully transparent, and easy to navigate. Moreover, our models support data presented in the reports and the complete methodology is outlined in the report and the model.
*Interactive excel forecast model only available to clients purchasing a site license or higher.
“What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
To view the table of contents and know more details please visit MediPoint: Peripheral Vascular Stents for the Lower Extremity - Global Analysis and Market Forecasts report.
It is evident that currently the peripheral vascular stent market for the lower extremity is saturated with bare metal stents, followed by covered stents. However, as clinical data and appropriate reimbursement and costs are established, adoption of innovative stent technologies such as drug-eluting stents and bioabsorbable stents will increase in the future.
By the end of the forecast period, the competitive landscape will experience significant change due to the launch of bioabsorbable stents in the market, the expansion of approved indications to include infrapopliteal artery lesions and the entry of new companies such as 480 Biomedical. Regions Covered: US, France, Germany, Italy, Spain, UK, Japan, Brazil, China and India.
Market Model Features
An interactive excel forecast model based on primary research interviews and surveys with KOLs, physicians, industry participants and distributors is included in this report*. The forecast model is robust, fully transparent, and easy to navigate. Moreover, our models support data presented in the reports and the complete methodology is outlined in the report and the model.
*Interactive excel forecast model only available to clients purchasing a site license or higher.
“What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.
To view the table of contents and know more details please visit MediPoint: Peripheral Vascular Stents for the Lower Extremity - Global Analysis and Market Forecasts report.
No comments:
Post a Comment